These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8924269)

  • 1. Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in subjects with coronary artery disease.
    Hardman TC; Barlow R; Dubrey SW; Croft P; Lant AF
    Am J Hypertens; 1996 Feb; 9(2):184-7. PubMed ID: 8924269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Metabolism; 1996 Oct; 45(10):1203-7. PubMed ID: 8843173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in black normotensive subjects compared with three other ethnic groups.
    Hardman TC; Croft P; Morrish Z; Anto-Awoakye K; Lant AF
    J Hum Hypertens; 1998 Jan; 12(1):29-34. PubMed ID: 9482130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies.
    Hardman TC; Thomas T; Lant AF
    J Membr Biol; 1998 Jan; 161(2):197-205. PubMed ID: 9435275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies surrounding erythrocyte sodium-lithium countertransport.
    Hardman TC; Lant AF
    J Hypertens; 1996 Jun; 14(6):695-703. PubMed ID: 8793691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kinetics.
    Hardman TC; Croft P; Barlow R; Wierzbicki AS; Feher MD; Lant AF
    J Hum Hypertens; 1995 Aug; 9(8):687-9. PubMed ID: 8523392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension.
    Brearley CJ; Wood AJ; Aronson JK; Grahame-Smith DG
    J Hypertens; 1993 Feb; 11(2):147-53. PubMed ID: 8385174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte sodium-lithium countertransport activity in non-nephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Diabetes Care; 1996 Jan; 19(1):32-8. PubMed ID: 8720530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension.
    Hardman TC; Wierzbicki AS; Croft P; Feher M; Cox A; Lant AF
    J Hum Hypertens; 1996 Jun; 10(6):429-30. PubMed ID: 8872813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension.
    Rutherford PA; Thomas TH; Laker MF; Wilkinson R
    Eur J Clin Invest; 1992 Nov; 22(11):719-24. PubMed ID: 1478240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catamenial variations in erythrocyte sodium-lithium countertransport and blood pressure.
    Adebayo GI; Hemeryck L; Hall M; Gasparro D; Sinnott M; Feely J
    Clin Sci (Lond); 1997 Jul; 93(1):29-34. PubMed ID: 9279200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of erythrocyte Na+/Li+ countertransport kinetics by two types of thiol group.
    Thomas TH; West IC; Wilkinson R
    Biochim Biophys Acta; 1995 May; 1235(2):317-22. PubMed ID: 7756341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of red cell sodium-lithium countertransport measurement--influence of different loading conditions.
    Besch W; Schläger D; Brahm J; Kohnert KD
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):715-9. PubMed ID: 8608193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects.
    Zerbini G; Ceolotto G; Gaboury C; Mos L; Pessina AC; Canessa M; Semplicini A
    Hypertension; 1995 May; 25(5):986-93. PubMed ID: 7737738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction for the adverse influence of sodium-potassium cotransport on apparent sodium-lithium countertransport activity in human erythrocytes.
    Hardman TC; Morrish Z; Patel M; Chalkley S; Noble MI
    J Pharmacol Toxicol Methods; 2002; 47(1):19-24. PubMed ID: 12387935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
    Poch E; González-Núñez D; Compte M; De la Sierra A
    Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
    Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the temporal effect of alcohol on human erythrocyte sodium-lithium countertransport in relation to membrane cholesterol and phospholipids.
    Adebayo GI; Gaffney P; Feely J
    Alcohol; 1996; 13(6):597-602. PubMed ID: 8949955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.